Skip to main content
. 2024 Jul 22;115(10):3384–3393. doi: 10.1111/cas.16281

FIGURE 1.

FIGURE 1

Patient flow diagram. Flow diagram of patients with newly diagnosed classic Hodgkin lymphoma enrolled in the JCOG1305 study using interim PET‐guided ABVD or ABVD/escalated BEACOPP therapy. ABVD, doxorubicin, bleomycin, vinblastine, and dacarbazine; eBEACOPP, escalated bleomycin, etoposide, doxorubicin, cyclophosphamide, vincristine, procarbazine, and prednisone; ISRT, involved site radiation therapy; PET, positron emission tomography.